0000000000591062

AUTHOR

Britta Vallazza

showing 3 related works from this author

Improving mRNA-Based Therapeutic Gene Delivery by Expression-Augmenting 3' UTRs Identified by Cellular Library Screening.

2019

Synthetic mRNA has emerged as a powerful tool for the transfer of genetic information, and it is being explored for a variety of therapeutic applications. Many of these applications require prolonged intracellular persistence of mRNA to improve bioavailability of the encoded protein. mRNA molecules are intrinsically unstable and their intracellular kinetics depend on the UTRs embracing the coding sequence, in particular the 3′ UTR elements. We describe here a novel and generally applicable cell-based selection process for the identification of 3′ UTRs that augment the expression of proteins encoded by synthetic mRNA. Moreover, we show, for two applications of mRNA therapeutics, namely, (1) …

Untranslated regionCellular differentiationRNA StabilityInduced Pluripotent Stem CellsBlood DonorsComputational biologyGene deliveryBiologyCancer Vaccines03 medical and health sciencesMice0302 clinical medicineDrug DiscoveryGeneticsCoding regionAnimalsHumansRNA MessengerInduced pluripotent stem cellMolecular BiologyGene3' Untranslated RegionsCells Cultured030304 developmental biologyGene LibraryPharmacology0303 health sciencesMessenger RNAMice Inbred BALB CVaccinationGene Transfer TechniquesGenetic TherapyFibroblastsCellular Reprogramming030220 oncology & carcinogenesisMolecular MedicineFemaleOriginal ArticleReprogrammingHalf-LifeMolecular therapy : the journal of the American Society of Gene Therapy
researchProduct

Determinants of intracellular RNA pharmacokinetics: Implications for RNA-based immunotherapeutics

2011

RNAs with optimized properties are increasingly investigated as a tool to deliver the genetic information of complete antigens into professional antigen-presenting dendritic cells for HLA haplotype-independent antigen-specific vaccination against cancer. As the dose of the antigen and duration of its presentation are critical factors for generating strong and sustained antigen-specific immune responses, improvement of the immunobioavailability of RNA-based vaccines has been a recurrent subject of research. Substantial increase of the amount of antigen produced from RNA can be achieved by optimizing RNA stability and translational efficiency. Both features are determined by cis-acting elemen…

RNA CapsRNA StabilityPolyadenylationTranslational efficiencyRNA Stabilitymedicine.medical_treatmentHuman leukocyte antigenComputational biologyBiologyPolyadenylationCancer VaccinesPoly(A)-Binding ProteinsAntigenNeoplasmsmedicineHumansDeoxyribonucleases Type II Site-Specific3' Untranslated RegionsMolecular BiologyAntigen PresentationThree prime untranslated regionRNADendritic CellsCell BiologyImmunotherapyVirologyRNAImmunotherapyPoly ARNA Biology
researchProduct

mRNA as a versatile tool for exogenous protein expression.

2012

Several viral and non-viral vectors have been developed for exogenous protein expression in specific cells. Conventionally, this purpose is achieved through the use of recombinant DNA. But mainly due to the risks associated with permanent genetic alteration of cells, safety and ethical concerns have been raised for the use of DNA-based vectors in human clinical therapy. In the last years, synthetic messenger RNA has emerged as powerful tool to deliver genetic information. RNA vectors exhibit several advantages compared to DNA and are particularly interesting for applications that require transient gene expression. RNA stability and translation efficiency can be increased by cis-acting struc…

RNA StabilityGenetic VectorsGene ExpressionComputational biologyBiologySmall hairpin RNADrug DiscoveryGene expressionGeneticsAnimalsHumansVector (molecular biology)RNA MessengerMolecular BiologyPost-transcriptional regulationGenetics (clinical)GeneticsMessenger RNAGene Transfer TechniquesRNAGenetic TherapyImmunity InnateRNA silencingRegulatory sequenceMolecular MedicineProtein Processing Post-TranslationalCurrent gene therapy
researchProduct